Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hamilton Thorne Ltd T.HTL

Alternate Symbol(s):  HTLZF

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.


TSX:HTL - Post by User

Comment by retiredcfon Jun 10, 2020 6:36am
144 Views
Post# 31132024

RE:Eight Capital Buy $1.80

RE:Eight Capital Buy $1.80 While we've had a number of analysts speak about HTL on BNN (Takacsy, Stewart, Omelchak & Lato), after over a year, it's nice to see this company pick up some new coverage from investment firms. Slowly but steadily we're moving onto investors' radar. Next stop is the majors. GLTA

HAMILTON THORNE (CVE:HTL) ANALYST RATINGS HISTORY

6/9/2020 Eight Capital Set Price Target Buy C$1.80
6/2/2020 Pi Financial Set Price Target Buy C$1.45
4/29/2019 Beacon Securities Reiterated Rating Buy
2/12/2019 Acumen Capital Set Price Target Buy C$1.30
10/25/2017 Bloom Burton Reiterated Rating Buy
<< Previous
Bullboard Posts
Next >>